2021 Russia Tumor Marker Testing Database--Supplier Shares, Volume and Sales Segment Forecasts for Major Cancer Diagnostic Tests

2021 Russia Tumor Marker Testing Database--Supplier Shares, Volume and Sales Segment Forecasts for Major Cancer Diagnostic Tests

  • April 2021 •
  • Report ID: 5997032 •
  • Format: PDF
2021 Russia Tumor Marker Testing Database--Supplier Shares, Volume and Sales Segment Forecasts for Major Cancer Diagnostic Tests

This unique report provides information and analysis not available from any other published source.

The report is available by section, and can be customized to specific information needs and budget.

This database provides the 2020 supplier shares, the 2020-2025 volume and sales forecasts for major tumor markers, as well as comprehensive lists of companies developing or marketing new technologies and products by test, including:

ACTH, AFP, Beta-2 Microglobulin, CA 15-3/2729, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.